Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 561 entries
Sorted by: Best Match Show Resources per page
Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii.

International journal of antimicrobial agents

Vallejo JA, Beceiro A, Rumbo-Feal S, Rodríguez-Palero MJ, Russo TA, Bou G.
PMID: 26213382
Int J Antimicrob Agents. 2015 Jul 09; doi: 10.1016/j.ijantimicag.2015.05.021. Epub 2015 Jul 09.

This study aimed to increase the sensitivity of Caenorhabditis elegans as an infection model for detection of minor differences in virulence or fitness between different Acinetobacter baumannii strains with known resistance and virulence mechanisms. Selected A. baumannii strains and...

Cite
Vallejo JA, Beceiro A, Rumbo-Feal S, et al. Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii. Int J Antimicrob Agents. 2015;doi: 10.1016/j.ijantimicag.2015.05.021.
Vallejo, J. A., Beceiro, A., Rumbo-Feal, S., Rodríguez-Palero, M. J., Russo, T. A., & Bou, G. (2015). Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii. International journal of antimicrobial agents, . https://doi.org/10.1016/j.ijantimicag.2015.05.021
Vallejo, J A, et al. "Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii." International journal of antimicrobial agents vol. (2015). doi: https://doi.org/10.1016/j.ijantimicag.2015.05.021
Vallejo JA, Beceiro A, Rumbo-Feal S, Rodríguez-Palero MJ, Russo TA, Bou G. Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii. Int J Antimicrob Agents. 2015 Jul 09; doi: 10.1016/j.ijantimicag.2015.05.021. Epub 2015 Jul 09. PMID: 26213382.
Copy Download .nbib Format: NLM
Treatment and experimental therapeutics of blastomycosis.

International journal of antimicrobial agents

Georgiev VS.
PMID: 18611678
Int J Antimicrob Agents. 1995 Sep;6(1):1-12. doi: 10.1016/0924-8579(95)00016-2.

No abstract available.

Cite
Georgiev VS. Treatment and experimental therapeutics of blastomycosis. Int J Antimicrob Agents. 1995;6(1):1-12doi: 10.1016/0924-8579(95)00016-2.
Georgiev, V. S. (1995). Treatment and experimental therapeutics of blastomycosis. International journal of antimicrobial agents, 6(1), 1-12. https://doi.org/10.1016/0924-8579(95)00016-2
Georgiev, V S. "Treatment and experimental therapeutics of blastomycosis." International journal of antimicrobial agents vol. 6,1 (1995): 1-12. doi: https://doi.org/10.1016/0924-8579(95)00016-2
Georgiev VS. Treatment and experimental therapeutics of blastomycosis. Int J Antimicrob Agents. 1995 Sep;6(1):1-12. doi: 10.1016/0924-8579(95)00016-2. PMID: 18611678.
Copy Download .nbib Format: NLM
Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994.

International journal of antimicrobial agents

Akpede GO, Adeyemi O, Ambe JP.
PMID: 18611691
Int J Antimicrob Agents. 1995 Dec;6(2):91-7. doi: 10.1016/0924-8579(95)00023-9.

From 1991 to 1994, Staphylococcus aureus, untyped Coliform spp. and Salmonella spp., other Enterobacteriaceae and other bacteria were isolated from 40.7%, 37.6%, 19.5% and 2.2%, respectively, of 225 confirmed cases of septicaemia in postneonatal infants and children. Overall, 98.9%,...

Cite
Akpede GO, Adeyemi O, Ambe JP. Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994. Int J Antimicrob Agents. 1995;6(2):91-7doi: 10.1016/0924-8579(95)00023-9.
Akpede, G. O., Adeyemi, O., & Ambe, J. P. (1995). Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994. International journal of antimicrobial agents, 6(2), 91-7. https://doi.org/10.1016/0924-8579(95)00023-9
Akpede, G O, et al. "Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994." International journal of antimicrobial agents vol. 6,2 (1995): 91-7. doi: https://doi.org/10.1016/0924-8579(95)00023-9
Akpede GO, Adeyemi O, Ambe JP. Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994. Int J Antimicrob Agents. 1995 Dec;6(2):91-7. doi: 10.1016/0924-8579(95)00023-9. PMID: 18611691.
Copy Download .nbib Format: NLM
Resistance of some selected pathogens to antimicrobials in Hungary.

International journal of antimicrobial agents

Ludwig E, Konkoly Thege M, Arr M, Kovács G.
PMID: 18611692
Int J Antimicrob Agents. 1995 Dec;6(2):99-102. doi: 10.1016/0924-8579(95)00027-6.

Bacterial resistance is an increasingly severe problem in Hungary. According to the data from Péterfy Teaching Hospital, Budapest and from the country-wide network of Public Health Laboratories, penicillin resistant pneumococci, multiresistant Enterobacteriaceae and Pseudomonas aeruginosa are of major concern....

Cite
Ludwig E, Konkoly Thege M, Arr M, et al. Resistance of some selected pathogens to antimicrobials in Hungary. Int J Antimicrob Agents. 1995;6(2):99-102doi: 10.1016/0924-8579(95)00027-6.
Ludwig, E., Konkoly Thege, M., Arr, M., & Kovács, G. (1995). Resistance of some selected pathogens to antimicrobials in Hungary. International journal of antimicrobial agents, 6(2), 99-102. https://doi.org/10.1016/0924-8579(95)00027-6
Ludwig, E, et al. "Resistance of some selected pathogens to antimicrobials in Hungary." International journal of antimicrobial agents vol. 6,2 (1995): 99-102. doi: https://doi.org/10.1016/0924-8579(95)00027-6
Ludwig E, Konkoly Thege M, Arr M, Kovács G. Resistance of some selected pathogens to antimicrobials in Hungary. Int J Antimicrob Agents. 1995 Dec;6(2):99-102. doi: 10.1016/0924-8579(95)00027-6. PMID: 18611692.
Copy Download .nbib Format: NLM
Antibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aureus.

International journal of antimicrobial agents

Sato M, Tsuchiya H, Miyazaki T, Fujiwara S, Yamaguchi R, Kureshiro H, Iinuma M.
PMID: 18611712
Int J Antimicrob Agents. 1996 Apr;6(4):227-31. doi: 10.1016/0924-8579(95)00065-8.

Anti-candidal hydroxychalcone, 2,4,2'-trihydroxy-5'-methylchalcone (THMC), was investigated for its antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). THMC showed the minimum inhibitory concentrations of 25.0-50.0 mug/ml against tested 20 strains, at which the effect was based on a bacteriostatic action. THMC...

Cite
Sato M, Tsuchiya H, Miyazaki T, et al. Antibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 1996;6(4):227-31doi: 10.1016/0924-8579(95)00065-8.
Sato, M., Tsuchiya, H., Miyazaki, T., Fujiwara, S., Yamaguchi, R., Kureshiro, H., & Iinuma, M. (1996). Antibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aureus. International journal of antimicrobial agents, 6(4), 227-31. https://doi.org/10.1016/0924-8579(95)00065-8
Sato, M, et al. "Antibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aureus." International journal of antimicrobial agents vol. 6,4 (1996): 227-31. doi: https://doi.org/10.1016/0924-8579(95)00065-8
Sato M, Tsuchiya H, Miyazaki T, Fujiwara S, Yamaguchi R, Kureshiro H, Iinuma M. Antibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 1996 Apr;6(4):227-31. doi: 10.1016/0924-8579(95)00065-8. PMID: 18611712.
Copy Download .nbib Format: NLM
Which antibiotic is better for the treatment of infections of the lower respiratory tract?.

International journal of antimicrobial agents

Schwigon CD, Gabor M, Hartmann J, Mössinger R, Oberling M, Schubert U, Schwarck H, Springsklee M, Zinndorf J.
PMID: 18611724
Int J Antimicrob Agents. 1996 Apr;6:S73-7.

The efficacy and tolerance of mezlocillin and ampicillin/sulbactam were investigated in an open, comparative, multicentre study involving 96 patients. The high levels of efficacy of both ampicillin/sulbactam and mezlocillin, as previously documented in comprehensive in vitro studies, were confirmed...

Cite
Schwigon CD, Gabor M, Hartmann J, et al. Which antibiotic is better for the treatment of infections of the lower respiratory tract?. Int J Antimicrob Agents. 1996;6:S73-7
Schwigon, C. D., Gabor, M., Hartmann, J., Mössinger, R., Oberling, M., Schubert, U., Schwarck, H., Springsklee, M., & Zinndorf, J. (1996). Which antibiotic is better for the treatment of infections of the lower respiratory tract?. International journal of antimicrobial agents, 6S73-7.
Schwigon, C D, et al. "Which antibiotic is better for the treatment of infections of the lower respiratory tract?." International journal of antimicrobial agents vol. 6 (1996): S73-7.
Schwigon CD, Gabor M, Hartmann J, Mössinger R, Oberling M, Schubert U, Schwarck H, Springsklee M, Zinndorf J. Which antibiotic is better for the treatment of infections of the lower respiratory tract?. Int J Antimicrob Agents. 1996 Apr;6:S73-7. PMID: 18611724.
Copy Download .nbib Format: NLM
Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/metronidazole in elective colon and rectum surgery: a prospective and randomized quality control study in 422 patients.

International journal of antimicrobial agents

Menzel J, Bauer J, von Pritzbauer E, Klempa I.
PMID: 18611725
Int J Antimicrob Agents. 1996 Apr;6:S79-82.

As previous work has shown, antibiotic prophylaxis is highly effective in lowering wound infection rates in colorectal surgery. In order to establish quality control, the authors investigated the effectiveness of three different prophylactic antibiotic regimes in 422 patients in...

Cite
Menzel J, Bauer J, von Pritzbauer E, et al. Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/metronidazole in elective colon and rectum surgery: a prospective and randomized quality control study in 422 patients. Int J Antimicrob Agents. 1996;6:S79-82
Menzel, J., Bauer, J., von Pritzbauer, E., & Klempa, I. (1996). Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/metronidazole in elective colon and rectum surgery: a prospective and randomized quality control study in 422 patients. International journal of antimicrobial agents, 6S79-82.
Menzel, J, et al. "Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/metronidazole in elective colon and rectum surgery: a prospective and randomized quality control study in 422 patients." International journal of antimicrobial agents vol. 6 (1996): S79-82.
Menzel J, Bauer J, von Pritzbauer E, Klempa I. Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/metronidazole in elective colon and rectum surgery: a prospective and randomized quality control study in 422 patients. Int J Antimicrob Agents. 1996 Apr;6:S79-82. PMID: 18611725.
Copy Download .nbib Format: NLM
Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae.

International journal of antimicrobial agents

Grimm H.
PMID: 18611726
Int J Antimicrob Agents. 1996 Apr;6:S9-S14.

Clavulanic acid and sulbactam alone are ineffective against Pseudomonas and enterococci. Staphylococci and Enterobacteriaceae are inhibited by high concentrations not attainable under clinical conditions. Strains of Acinetobacter, especially A. lwoffii are susceptible to clavulanic acid and highly susceptible to...

Cite
Grimm H. Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae. Int J Antimicrob Agents. 1996;6:S9-S14
Grimm, H. (1996). Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae. International journal of antimicrobial agents, 6S9-S14.
Grimm, H. "Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae." International journal of antimicrobial agents vol. 6 (1996): S9-S14.
Grimm H. Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae. Int J Antimicrob Agents. 1996 Apr;6:S9-S14. PMID: 18611726.
Copy Download .nbib Format: NLM
Evolution of the antimicrobial susceptibility of B. fragilis group at the university hospital of Seville (Spain) between 1977 and 1995.

International journal of antimicrobial agents

Borobio MV, Pascual A, Dominguez MC, Suarez AI, Ramirez E, Conejo MC, Pallarés JA, Moreno R, Perea EJ.
PMID: 18611728
Int J Antimicrob Agents. 1996 May;7(1):1-7. doi: 10.1016/0924-8579(96)00002-7.

A susceptibility survey of the B. fragilis group divided into three periods was carried out between 1977 and 1995 at the University Hospital of Seville (Spain) using the agar dilution method. No chloramphenicol, imipenem or meropenem-resistant strains were found....

Cite
Borobio MV, Pascual A, Dominguez MC, et al. Evolution of the antimicrobial susceptibility of B. fragilis group at the university hospital of Seville (Spain) between 1977 and 1995. Int J Antimicrob Agents. 1996;7(1):1-7doi: 10.1016/0924-8579(96)00002-7.
Borobio, M. V., Pascual, A., Dominguez, M. C., Suarez, A. I., Ramirez, E., Conejo, M. C., Pallarés, J. A., Moreno, R., & Perea, E. J. (1996). Evolution of the antimicrobial susceptibility of B. fragilis group at the university hospital of Seville (Spain) between 1977 and 1995. International journal of antimicrobial agents, 7(1), 1-7. https://doi.org/10.1016/0924-8579(96)00002-7
Borobio, M V, et al. "Evolution of the antimicrobial susceptibility of B. fragilis group at the university hospital of Seville (Spain) between 1977 and 1995." International journal of antimicrobial agents vol. 7,1 (1996): 1-7. doi: https://doi.org/10.1016/0924-8579(96)00002-7
Borobio MV, Pascual A, Dominguez MC, Suarez AI, Ramirez E, Conejo MC, Pallarés JA, Moreno R, Perea EJ. Evolution of the antimicrobial susceptibility of B. fragilis group at the university hospital of Seville (Spain) between 1977 and 1995. Int J Antimicrob Agents. 1996 May;7(1):1-7. doi: 10.1016/0924-8579(96)00002-7. PMID: 18611728.
Copy Download .nbib Format: NLM
Famciclovir, from the bench to the patient--a comprehensive review of preclinical data.

International journal of antimicrobial agents

Bacon TH.
PMID: 18611746
Int J Antimicrob Agents. 1996 Jul;7(2):119-34. doi: 10.1016/0924-8579(96)00303-2.

Famciclovir is converted rapidly and efficiently after oral administration to the selective antiviral compound, penciclovir. In cell culture, penciclovir is a potent inhibitor of herpes simplex virus (HSV) types 1 and 2, varicella-zoster virus (VZV), Epstein-Barr virus (EBV) and...

Cite
Bacon TH. Famciclovir, from the bench to the patient--a comprehensive review of preclinical data. Int J Antimicrob Agents. 1996;7(2):119-34doi: 10.1016/0924-8579(96)00303-2.
Bacon, T. H. (1996). Famciclovir, from the bench to the patient--a comprehensive review of preclinical data. International journal of antimicrobial agents, 7(2), 119-34. https://doi.org/10.1016/0924-8579(96)00303-2
Bacon, T H. "Famciclovir, from the bench to the patient--a comprehensive review of preclinical data." International journal of antimicrobial agents vol. 7,2 (1996): 119-34. doi: https://doi.org/10.1016/0924-8579(96)00303-2
Bacon TH. Famciclovir, from the bench to the patient--a comprehensive review of preclinical data. Int J Antimicrob Agents. 1996 Jul;7(2):119-34. doi: 10.1016/0924-8579(96)00303-2. PMID: 18611746.
Copy Download .nbib Format: NLM
Identification and mapping of new chromosomal sites affecting response to beta-lactams in Staphylococcus aureus.

International journal of antimicrobial agents

Vasilieva E, Labischinski H, Berger-Bächi B.
PMID: 18611780
Int J Antimicrob Agents. 1997 Feb;8(1):13-21. doi: 10.1016/s0924-8579(96)00346-9.

Seven new sites leading to increased beta-lactam susceptibility were identified and mapped in Staphylococcus aureus by Tn551 or Tn917 mediated insertional inactivation. Their effect was more pronounced in methicillin resistant than in susceptible strains. Except for inserts each in...

Cite
Vasilieva E, Labischinski H, Berger-Bächi B. Identification and mapping of new chromosomal sites affecting response to beta-lactams in Staphylococcus aureus. Int J Antimicrob Agents. 1997;8(1):13-21doi: 10.1016/s0924-8579(96)00346-9.
Vasilieva, E., Labischinski, H., & Berger-Bächi, B. (1997). Identification and mapping of new chromosomal sites affecting response to beta-lactams in Staphylococcus aureus. International journal of antimicrobial agents, 8(1), 13-21. https://doi.org/10.1016/s0924-8579(96)00346-9
Vasilieva, E, et al. "Identification and mapping of new chromosomal sites affecting response to beta-lactams in Staphylococcus aureus." International journal of antimicrobial agents vol. 8,1 (1997): 13-21. doi: https://doi.org/10.1016/s0924-8579(96)00346-9
Vasilieva E, Labischinski H, Berger-Bächi B. Identification and mapping of new chromosomal sites affecting response to beta-lactams in Staphylococcus aureus. Int J Antimicrob Agents. 1997 Feb;8(1):13-21. doi: 10.1016/s0924-8579(96)00346-9. PMID: 18611780.
Copy Download .nbib Format: NLM
Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative.

International journal of antimicrobial agents

Szpakowska M, Reiss J, Graczyk A, Szmigielski S, Lasocki K, Grzybowski J.
PMID: 18611781
Int J Antimicrob Agents. 1997 Feb;8(1):23-7. doi: 10.1016/s0924-8579(96)00353-6.

The photodynamic effect of the arginine hematoporphyrin derivative (HpD-Arg(2)) on the growth of selected Pseudomonas aeruginosa clinical isolates is described as compared to the effect of hematoporphyrin derivative (HpD). Growth inhibition of HpD-Arg(2) of three Gram-positive strains (Staphylococcus aureus,...

Cite
Szpakowska M, Reiss J, Graczyk A, et al. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents. 1997;8(1):23-7doi: 10.1016/s0924-8579(96)00353-6.
Szpakowska, M., Reiss, J., Graczyk, A., Szmigielski, S., Lasocki, K., & Grzybowski, J. (1997). Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. International journal of antimicrobial agents, 8(1), 23-7. https://doi.org/10.1016/s0924-8579(96)00353-6
Szpakowska, M, et al. "Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative." International journal of antimicrobial agents vol. 8,1 (1997): 23-7. doi: https://doi.org/10.1016/s0924-8579(96)00353-6
Szpakowska M, Reiss J, Graczyk A, Szmigielski S, Lasocki K, Grzybowski J. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents. 1997 Feb;8(1):23-7. doi: 10.1016/s0924-8579(96)00353-6. PMID: 18611781.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 561 entries